SCHEMBL9572914

SCHEMBL9572914

CCCCCC(=O)c1[nH]c2ccccc2c1NC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.50
▸ ALDH1A1 P00352 7/20 0.50
▸ HSD17B10 Q99714 7/20 0.50
▸ HPGD P15428 5/20 0.50
▸ TSHR P16473 4/20 0.49
▸ GAA P10253 5/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ OXER1 Q8TDS5 1/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ GFER P55789 1/20 0.47
▸ LMNA P02545 2/20 0.45
▸ MGAM O43451 1/20 0.45
▸ SI P14410 1/20 0.45
▸ MGAM2 Q2M2H8 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ GABRA1 P14867 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9573321 0.84 EPHX2 (0.50) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL16254239 0.77 ALDH1A1 (0.55) KDM4EALDH1A1HSD17B10HPGDGAA
SCHEMBL9572939 0.77 ALOX15 (0.45) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL14602583 0.76 KDM4E (0.58) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL9572816 0.76 EPHX2 (0.54) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL9268276 0.76 OXER1 (0.62) KDM4EALDH1A1HPGDHTTOXER1
SCHEMBL15512501 0.76 OXER1 (0.62) KDM4EALDH1A1HPGDHTTOXER1
SCHEMBL17022468 0.72 OXER1 (0.62) KDM4EALDH1A1HSD17B10HPGDGAA
Carbazole SCHEMBL28847016 0.72 OXER1 (0.61) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL5728171 0.72 KDM4E (0.64) KDM4EALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562832-A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use SANKYO COMPANY LIMITED (JP) 1993-09-29 — — EP disclosed
Send feedback